Asia-Pacific Injection Pen Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis By Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)

No. of Pages: 144
Report Code: BMIRE00028184
Category: Life Sciences
Asia-Pacific Injection Pen Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia-Pacific Injection Pen Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia-Pacific Injection Pen Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia-Pacific Injection Pen Market Regional Analysis

6.2 Asia-Pacific Injection Pen Market Revenue 2020-2028 (US$ Million)
6.3 Asia-Pacific Injection Pen Market Forecast Analysis

7. Asia-Pacific Injection Pen Market Analysis – by Type

7.1 Disposable Injection Pens
  • 7.1.1 Overview
  • 7.1.2 Disposable Injection Pens: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Reusable Injection Pens
  • 7.2.1 Overview
  • 7.2.2 Reusable Injection Pens: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia-Pacific Injection Pen Market Analysis – by Therapy

8.1 Diabetes
  • 8.1.1 Overview
  • 8.1.2 Diabetes: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Growth Hormone Therapy
  • 8.2.1 Overview
  • 8.2.2 Growth Hormone Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Autoimmune Diseases
  • 8.3.1 Overview
  • 8.3.2 Autoimmune Diseases: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Fertility
  • 8.4.1 Overview
  • 8.4.2 Fertility: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Cancer
  • 8.5.1 Overview
  • 8.5.2 Cancer: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.6 Others Therapy
  • 8.6.1 Overview
  • 8.6.2 Others Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Asia-Pacific Injection Pen Market Analysis – by End User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals and Clinics: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Home Care
  • 9.2.1 Overview
  • 9.2.2 Home Care: Asia-Pacific Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Asia-Pacific Injection Pen Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia-Pacific Injection Pen Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.2.1.1 Asia-Pacific Injection Pen Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 China: Asia-Pacific Injection Pen Market Breakdown, by Type
    • 10.2.1.1.2 China: Asia-Pacific Injection Pen Market Breakdown, by Therapy
    • 10.2.1.1.3 China: Asia-Pacific Injection Pen Market Breakdown, by End User
  • 10.2.1.2 India: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 India: Asia-Pacific Injection Pen Market Breakdown, by Type
    • 10.2.1.2.2 India: Asia-Pacific Injection Pen Market Breakdown, by Therapy
    • 10.2.1.2.3 India: Asia-Pacific Injection Pen Market Breakdown, by End User
  • 10.2.1.3 Japan: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 Japan: Asia-Pacific Injection Pen Market Breakdown, by Type
    • 10.2.1.3.2 Japan: Asia-Pacific Injection Pen Market Breakdown, by Therapy
    • 10.2.1.3.3 Japan: Asia-Pacific Injection Pen Market Breakdown, by End User
  • 10.2.1.4 Australia: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Australia: Asia-Pacific Injection Pen Market Breakdown, by Type
    • 10.2.1.4.2 Australia: Asia-Pacific Injection Pen Market Breakdown, by Therapy
    • 10.2.1.4.3 Australia: Asia-Pacific Injection Pen Market Breakdown, by End User
  • 10.2.1.5 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market Breakdown, by Type
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market Breakdown, by Therapy
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia-Pacific Injection Pen Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 AstraZeneca Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Becton Dickinson and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Eli Lilly and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Gerresheimer AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Haselmeier GmbH
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck KGaA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novo Nordisk AS
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Owen Mumford Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sanofi SA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia-Pacific Injection Pen Market

  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Eli Lilly and Co
  • Gerresheimer AG
  • Haselmeier GmbH
  • Merck KGaA
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)